Answers are grounded in this paper and cite their sources.
Chronic ocular Stevens–Johnson syndrome (SJS) is characterized by persistent inflammation, conjunctival fibrosis, and progressive ocular surface dysfunction, but the molecular mechanisms underlying extracellular matrix (ECM) remodeling remain poorly understood. We characterized the conjunctival transcriptomic landscape of chronic ocular SJS and investigated the functional relevance of extracellular matrix protein 1 (ECM1). Bulk RNA sequencing was performed on conjunctival tissues from patients with chronic ocular SJS (n = 5) and healthy controls (n = 4), followed by differential expression and pathway enrichment analyses. ECM1 was further validated by quantitative real-time PCR, immunofluorescence, and ELISA, while gelatin zymography was used to assess matrix metalloproteinase activity. Transcriptomic profiling revealed marked dysregulation of inflammatory and ECM-associated pathways, with ECM1 among the prominently upregulated genes. Recombinant ECM1 treatment of human conjunctival epithelial cells increased expression of pro-inflammatory mediators, including IL1B, IL1A, IL6, and IL36G, together with ECM remodeling-associated genes. ECM1 exposure also enhanced cell adhesion and angiogenic responses in vitro. These findings identify ECM1 as a potential mediator linking inflammation, ECM remodeling, and angiogenic responses in chronic ocular SJS and support further investigation of ECM1-associated pathways as potential therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Goel et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: